Το Διοικητικό Συμβούλιο της ΕΙΕΚ σας εύχεται Καλές Γιορτές!

1η Πανελλήνια Επιστημονική Συνάντηση για Τα κανναβινοειδή. 22 και 23 Νοεμβρίου 2024 , Αθήνα

Ενημέρωση έκδοσης βιβλίου “ΕΝΔΟΚΑΝΝΑΒΙΝΟΕΙΔΕΣ ΣΥΣΤΗΜΑ ΚΑΙ ΚΑΝΝΑΒΗ – Η επιστημονική βάση” από τις Εκδόσεις Λευκό Μελάνι.

Αλλαγή θέσης της κάνναβης στον πίνακα ναρκωτικών

The relationship between cannabis and anorexia nervosa: a scoping review. J Eat Disord. 2023

Cannabis-Impaired driving: ethical considerations for the primary care practitioner. Ann Med. 2023

Hemp & Cannabidiol: What is a Medicine?

Psychiatric Disorders and Cannabinoid Receptors. Adv Exp Med Biol. 2021

The evolution of cannabinoid receptors in cancer. WIREs Mech Dis. 2023

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev. 2023

Cannabis as a Source of Approved Drugs: A New Look at an Old Problem. Molecules. 2023

Cannabis Use, Lung Cancer, and Related Issues. J Thorac Oncol. 2018

Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L.Molecules. 2024 J

The Cannabis Terpenes.Molecules. 2020

1η Πανελλήνια Επιστημονική Συνάντηση για τα Κανναβινοειδή

Cannabis use in Parkinson’s disease: Patient access to medical cannabis and physician perspective on product safety. Neurotoxicology. 2024 Jun

Haller J. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel). 2024 M

Yang J, Lin N, Li S, Dong Z, Wang D, Liu Y, Zhou Y, Yuan H. Cannabidiol Alleviates Oral Mucositis by Inhibiting PI3K/Akt/NF-κB-Mediated Pyroptosis. Balkan Med J. 2024

Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution.Cardiovasc Med. 2024 Jun 21

14o Πανελλήνιο Συνέδριο Αλγολογίας

Ιατρικό Διαδικτυακό Σεμινάριο

Τα οφέλη της φαρμακευτικής κάνναβης- η πρώτη συνταγή στο νοσοκομείο Παπαγεωργίου

Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin. Rev Invest Clin. 2023

Genome-wide DNA methylation association study of recent and cumulative marijuana use in middle aged adults. Mol Psychiatry. 2023 Jun

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Database Syst Rev. 2022

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024 Mar

6o Webinar

Συνταγογράφηση ιατρικής κάνναβης στην Ελλάδα

Συνταγογράφηση κάνναβης στην Ελλάδα

Φαρμακευτική κάνναβη: η γιατρός που χορήγησε το πρώτο σκεύασμα εξηγεί ποιοι θα ωφεληθούν και ποιοι κινδυνεύουν

Greece welcomes ‘new era’ of medical cannabis after seven-year wait

Φαρμακευτική κάνναβη: η πρώτη συνταγή στην Ελλάδα

Ξεκίνησε η χορήγηση θεραπευτικής κάνναβης από τα φαρμακεία | ACTION Τώρα | ACTION 24

ΠΡΟΓΡΑΜΜΑ ΔΙΑΔΙΚΤΥΑΚΩΝ ΜΑΘΗΜΑΤΩΝ ΤΗΣ ΕΙΕΚ 2023-24

Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals (Basel). 2023

The Polypharmacological Effects of Cannabidiol. Molecules. 2023

Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines. 2023

Should oncologists trust cannabinoids? Front Pharmacol. 2023

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines. 2023

Cannabinoids in Treating Chemotherapy-Induced Nausea and Vomiting, Cancer-Associated Pain, and Tumor Growth. Int J Mol Sci. 2023

The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management. Cureus. 2023

Role of Cannabinoids in Oral Cancer. Int J Mol Sci. 2024

Υπαγωγή ουσίας και των παραγώγων της στις διατάξεις του Kώδικα Νόμων για τα Ναρκωτικά (Κ.Ν.Ν.) (ν.3459/2006, Α΄103), όπως τροποποιήθηκε με τον ν. 4139/2013«Νόμος περί εξαρτησιογόνων ουσιών και άλλες διατάξεις» (Α΄ 74).

Cannabinoid receptor 2 signal promotes type 2 immunity in the lung. Cell Insight. 2023 Oct

Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study. J Pain Res. 2023 Oct

Plant Extracts as Skin Care and Therapeutic Agents. Int J Mol Sci. 2023 Oct

Tetrahydrocannabinol in Pediatrics: Room for Improvement? Med Cannabis Cannabinoids. 2023 Oct

Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: A Quasi-Experimental Study. Med Cannabis Cannabinoids. 2023 Nov

CANNABIS USE AND THE DEVELOPING BRAIN: HIGHS AND LOWS. Front Young Minds. 2023

Improved Post-Traumatic Stress Disorder Symptoms and Related Sleep Disturbances after Initiation of Medical Marijuana Use: Evidence froma Prospective Single Arm Pilot Study. Med Cannabis Cannabinoids. 2023 Nov

Does Cannabis Cause Heart Failure and Stroke?

3ο Webinar

Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth. 2019

Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions Rambam Maimonides Med J. 2023

Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2020

Syncope and Cannabis: hypervagotonia from chronic abuse? A case report and literature review. BMC Cardiovasc Disord. 2023

Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults. Biomedicines. 2023

Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use. Med Cannabis Cannabinoids. 2023

The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain. J Cannabis Res. 2023 Nov 9;5(1):38.

Role of Terpenophenolics in Modulating Inflammation and Apoptosis in Cardiovascular Diseases: A Review. Int J Mol Sci. 2023

Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology. Adv Pharmacol. 2023

Rorabaugh BR, Guindon J, Morgan DJ. Role of cannabinoid signaling in cardiovascular function and ischemic injury. J Pharmacol Exp Ther. 2023

Hemant Goyal, Hamza H. Awad, Jalal K. Ghali.Role of cannabis in cardiovascular disorders

2o webinar

The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci. 2020

Molecular Mechanism of Cannabinoids in Cancer Progression. Int. J. Mol. Sci. 2021

Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns. World J Clin Cases. 2023

Molecular and Cellular Mechanisms of Action of Cannabidiol. Molecules. 2023

Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings. Prague Med Rep. 2023

The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial. Eur J Pain. 2020

Meccariello R. Molecular Advances on Cannabinoid and Endocannabinoid Research. Int J Mol Sci. 2023

High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells. Heliyon. 2023

Endocannabinoid release at ventral hippocampal-amygdala synapses regulates stress-induced behavioral adaptation. Cell Rep. 2023

Prophylactic Effects of Hemp Seed Oil on Perimenopausal Depression: A Role of HPA Axis. J Oleo Sci. 2023

Informing the Cannabis Conjecture: From Life’s Beginnings to Mitochondria, Membranes and the Electrome—A Review.  International Journal of Molecular Sciences. 2023;

To Weed or Not to Weed: A Systematic Review Exploring the Potential for Cannabis Use in Cardiovascular Disease, Mental Health and Pain Management. Cureus. 2023

Variant Angina and Cannabis-Induced Myocarditis: A Rare Presentation of Myocardial Inflammation. Cureus. 2023

Could cannabinoids provide a new hope for ovarian cancer patients? Pharmacol Res Perspect. 2023

Cannabis Use and Associated Gastrointestinal Disorders: A Literature Review. Cureus,2023

Cannabis Versus Opioids for Pain. StatPearls Publishing 2023

Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial. Pharmaceuticals (Basel). 2023

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ 2023

Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study. PLoS One. 2023

Is Cannabis Effective in the Treatment of Chronic Back Pain? Cureus. 2023

Πρoστατευμένο: 1o webinar ΟΚΤΩΒΡΙΟΣ 2023

Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review. BMJ OPEN 2020.

Ημερίδα Αλγολογίας 24 & 25 Ιουνίου 2023, Αίγινα, Ξενοδοχείο DANAE

Cannabis: are there any benefits? Intern Med J. 2020

25ο Πανελλήνιο Συνέδριο Αναισθησιολογίας

Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, NewYork State, 2017-2019

Medical Reasons for Marijuana Use, Forms of Use,and Patient Perception of Physician Attitudes Among the US Population.J Gen Intern Med. 2020

ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023

The Trouble with CBD Oil. Med Cannabis Cannabinoids. 2018

Le Foll B. Opioid-sparing effects of cannabinoids: Myth or reality?

The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003

Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain 2021

Cannabinoids in cancer treatment: Therapeutic potential and legislation

The endocannabinoid system : an overview

The use of medical cannabis concomitantly with immunecheckpoint inhibitors in non-small cell lung cancer: A sigh of relief?

Δελτίο Τύπου αναφορικά με την ίδρυση της Ελληνικής Ιατρικής Εταιρείας Κανναβινοειδών (ΕΙΕΚ)